Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma

Clinical trial NCT01955395 · COMPLETED

Trial details

NCT number: NCT01955395
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Monoclonal Gammopathy of Undetermined Significance Smoldering Multiple Myeloma

Start date: 2013-10-01
Primary completion: 2016-09-01
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.